Key Takeaways:
- Innovation Push: New model focuses on science-based innovation across all price tiers to drive category growth
- Price Projection: Based on current assumptions, CL stock could reach $101 by December 2027
- Potential Gains: This target implies a total return of 16.7% from the current price of $87
- Annual Return: Investors could see roughly 8.3% annual growth over the next 1.9 years
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>
Colgate-Palmolive (CL) is navigating a challenging consumer environment, but the company is making strategic moves that could unlock value for patient investors.
CEO Noel Wallace is executing a deliberate transformation through the company’s 2030 strategy. This isn’t wholesale change—it’s about accelerating what’s already working while adapting to current market realities.
The results show resilience despite headwinds:
- Strong market positions in growing categories with healthy brand shares
- Nearly 50% exposure to faster-growth emerging markets
- Continued positive pricing across all divisions in Q3
- Hill’s Pet Nutrition delivered 2.5% organic growth (excluding private label)
Consumer uncertainty, tariffs, and category slowdowns have pressured results. Global category growth slowed to roughly 2% in Q3 from 3% in the first half, well below the historical 4-5% pace.
But Colgate is adapting through increased innovation spending, AI-powered revenue management tools, and a new productivity program to fund growth investments.
See analysts’ full growth forecasts and estimates for CL stock (It’s free) >>>
What the Model Says for Colgate-Palmolive Stock
We analyzed Colgate through the lens of its transformation into a faster-growing, higher-margin business built on premium innovation and emerging market strength.
The company is methodically shifting its portfolio toward premium products while maintaining competitive positions across price tiers. Innovation like Colgate Total’s relaunch and Elmex’s European expansion is driving premiumization.
Meanwhile, the Strategic Growth and Productivity Program (SGPP) will free up resources to fund these initiatives.
Using a forecast of 2.6% annual revenue growth and 21.6% operating margins, our model projects the stock will rise to $101 within 1.9 years, assuming a 23x price-to-earnings multiple.
That represents a slight compression from Colgate’s current P/E of 23x. The company trades near its historical average as it balances short-term category weakness with long-term strategic investments.
As premium innovation scales and emerging markets reaccelerate, the multiple should hold steady or expand modestly.
The real value lies in executing the omnichannel strategy and scaling capabilities in digital, AI, premiumization, and personalized marketing.
Our Valuation Assumptions
Estimate a company’s fair value instantly (Free with TIKR) >>>
Our Valuation Assumptions
TIKR’s Valuation Model lets you plug in your own assumptions for a company’s revenue growth, operating margins, and P/E multiple, and calculates the stock’s expected returns.
Here’s what we used for CL stock:
1. Revenue Growth: 2.6%
Colgate’s growth story centers on premiumization, expansion into emerging markets, and category stimulation.
Premium Innovation: Colgate Total is driving record shares in Asia and recovering in Latin America after formula adjustments. Elmex is delivering record shares in European pharmacy channels. The company is investing heavily in therapeutic and whitening segments.
Emerging Markets: Latin America’s organic growth was up mid-single digits in Mexico and Brazil, despite challenges in Colombia and Central America. India faces near-term headwinds from GST tax changes but should benefit in the long term. China’s Colgate brand grew mid-single digits on e-commerce strength.
Hill’s Momentum: The pet nutrition business is gaining share across strategic segments like cat, wet food, and therapeutic diets. Therapeutic (prescription diet) continues to grow strongly. The Tonganoxie facility expansion unlocks wet food capacity.
2. Operating margins: 21.6%
Colgate is protecting margins while investing in growth.
Current Performance: Gross margin pressures from raw materials (particularly Palm oil), tariffs, and transactional FX were offset by positive pricing across all divisions. Consumer Wireline at Hill’s saw margin expansion.
SGPP Benefits: The productivity program aims to deliver $200-300 million in savings through 2028. These funds increased advertising, innovation resources, and AI investments while delivering dollar-based EPS growth.
AI and Efficiency: Investments in agentic AI, demand planning automation, and supply chain optimization are improving asset utilization and reducing working capital needs.
3. Exit P/E Multiple: 22.9x
The market currently values Colgate at 23x earnings. We assume the multiple compresses slightly to 22.9x through our forecast period.
Near Historical Average: Colgate’s P/E has averaged 22.9x over the past year and 24.1x over five years. The modest compression acknowledges the challenges of category growth and competitive intensity.
Quality Premium: As innovation accelerates and emerging markets rebound, Colgate should maintain its quality multiple. The company generates strong cash flow, holds leading global positions, and is strategically investing in future growth platforms.
Build your own Valuation Model to value any stock (It’s free!) >>>
What Happens If Things Go Better or Worse?
Consumer goods companies face category volatility and competitive pressure. Here’s how Colgate stock might perform under different scenarios through December 2029:
- Low Case: If revenue growth slows to 2.4% and margins contract to 13.9%, the stock could still deliver a 2.3% annual return.
- Mid Case: With 2.6% growth and 14.8% net margins, we expect an annual return of 7.4%.
- High Case: If premium innovation accelerates and Colgate maintains 15.5% net margins while growing at 2.9%, returns could hit 11.7% annually.
See what analysts think about CL stock right now (Free with TIKR) >>>
The range reflects execution on the 2030 strategy, category recovery timing, and competitive dynamics across regions.
How Much Upside Does Colgate-Palmolive Stock Have From Here?
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
See a stock’s true value in under 60 seconds (Free with TIKR) >>>
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
